TP53 and neoplasm: In addition, in brain tumour patients, oxidative stress can also arise from the unusual generation of free radicals and low expression or inactivation of antioxidant defence by mutations of tumour suppressor genes, like mutant BRCA1 and p53, and attenuated activation and function of nuclear factors [34–36].